Page History

...

CDISC specifies how to structure the data that has been collected in a database, not what should be collected or how to conduct clinical assessments or protocols. CDISC disclaims any liability for your use of this material.

Although the United States Food and Drug Administration (US FDA) has provided input with regard to this supplement, this input does not constitute US FDA endorsement of any particular instrument.

...

Reference for the NSCLC-SAQ V1.0:

• Patient-Reported Outcome (PRO) Consortium - Non-Small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ) Provisional User Manual, Version 6: March 24, 2017.

  Jira
  server Issue Tracker (JIRA) columns key,summary,type,created,updated,due,assignee,reporter,priority,status,resolution serverId 85506ce4-3cb3-3d91-85ee-f633aaaf4a45 key QRSSUPP-227

• McCarrier KP, Atkinson TM, DeBusk KP, Liepa AM, Scanlon M, Coons SJ and on behalf of the Patient-Reported Outcome Consortium. Qualitative Development and Content Validity of the Non-small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ), A Patient-reported Outcome Instrument. Clinical Therapeutics

  Jira
  showSummary false server Issue Tracker (JIRA) serverId 85506ce4-3cb3-3d91-85ee-f633aaaf4a45 key QRSSUPP-228

  2016; 38(4):794-810.
  

...